Literature DB >> 11384965

Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.

D Siegmund1, D Mauri, N Peters, P Juo, M Thome, M Reichwein, J Blenis, P Scheurich, J Tschopp, H Wajant.   

Abstract

Fas, a death domain-containing member of the tumor necrosis factor receptor family and its ligand FasL have been predominantly studied with respect to their capability to induce cell death. However, a few studies indicate a proliferation-inducing signaling activity of these molecules too. We describe here a novel signaling pathway of FasL and the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) that triggers transcriptional activation of the proto-oncogene c-fos, a typical target gene of mitogenic pathways. FasL- and TRAIL-mediated up-regulation of c-Fos was completely dependent on the presence of Fas-associated death domain protein (FADD) and caspase-8, but caspase activity seemed to be dispensable as a pan inhibitor of caspases had no inhibitory effect. Upon overexpression of the long splice form of cellular FADD-like interleukin-1-converting enzyme (FLICE) inhibitory protein (cFLIP) in Jurkat cells, FasL- and TRAIL-induced up-regulation of c-Fos was almost completely blocked. The short splice form of FLIP, however, showed a rather stimulatory effect on c-Fos induction. Together these data demonstrate the existence of a death receptor-induced, FADD- and caspase-8-dependent pathway leading to c-Fos induction that is inhibited by the long splice form FLIP-L.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384965     DOI: 10.1074/jbc.M100444200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic mice.

Authors:  Jin-Young Shin; Il-Hee Yoon; Jong-Hyung Lim; Jun-Seop Shin; Hye-Young Nam; Yong-Hee Kim; Hyoung-Soo Cho; So-Hee Hong; Jung-Sik Kim; Won-Woo Lee; Chung-Gyu Park
Journal:  Cell Mol Immunol       Date:  2015-07-27       Impact factor: 11.530

2.  CD95-mediated alteration in Hsp70 levels is dependent on protein stabilization.

Authors:  Caoimhín G Concannon; Una FitzGerald; Carina I Holmberg; Eva Szegezdi; Lea Sistonen; Afshin Samali
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

Review 3.  Death receptor signals to mitochondria.

Authors:  Roya Khosravi-Far; Mauro Degli Esposti
Journal:  Cancer Biol Ther       Date:  2004-11-18       Impact factor: 4.742

Review 4.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

5.  Activation of ASK-1 and downstream MAP kinases in cytochrome P4502E1 potentiated tumor necrosis factor alpha liver injury.

Authors:  Defeng Wu; Arthur Cederbaum
Journal:  Free Radic Biol Med       Date:  2010-05-14       Impact factor: 7.376

6.  Detection of soluble TRAIL in HBV infected patients and its clinical implications.

Authors:  Li-Hui Han; Wen-Sheng Sun; Chun-Hong Ma; Li-Ning Zhang; Su-Xia Liu; Qiu Zhang; Li-Fen Gao; You-Hai Chen
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

7.  TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.

Authors:  Laiqun Zhang; Martin R Dittmer; Ken Blackwell; Lauren M Workman; Bruce Hostager; Hasem Habelhah
Journal:  Cell Signal       Date:  2014-11-18       Impact factor: 4.315

8.  Fas activation in alveolar epithelial cells induces KC (CXCL1) release by a MyD88-dependent mechanism.

Authors:  Alex W Farnand; Alison J Eastman; Raquel Herrero; Josiah F Hanson; Steve Mongovin; William A Altemeier; Gustavo Matute-Bello
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-21       Impact factor: 6.914

9.  Prognostic significance of loss of c-fos protein in gastric carcinoma.

Authors:  Seon Pil Jin; Ji Hun Kim; Min A Kim; Han-Kwang Yang; Hee Eun Lee; Hye Seung Lee; Woo Ho Kim
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

10.  TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP.

Authors:  S Morioka; E Omori; T Kajino; R Kajino-Sakamoto; K Matsumoto; J Ninomiya-Tsuji
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.